COSETTE PHARMACEUTICALS, INC.

Cosette Pharmaceuticals, Inc. specializes in the manufacturing of sterile pharmaceutical preparations, with a focused expertise in autoinjector-based drug delivery systems for specialized therapeutics. The company demonstrates deep technical proficiency in aseptic processing, lyophilization, and prefilled syringe and autoinjector formulation development, particularly for peptide-based compounds such as bremelanotide. Their work on Vyleesi (bremelanotide) 1.75mg/0.3ml autoinjectors indicates advanced capabilities in biopharmaceutical manufacturing, including precise dosing mechanisms, container closure integrity, and stability validation under strict cGMP standards. The consistency in product specifications across multiple awards suggests a mature, repeatable manufacturing process compliant with FDA and VA regulatory expectations. The company maintains a sustained relationship with the Department of Veterans Affairs, supplying critical specialty pharmaceuticals for veteran healthcare programs. Their work supports VA’s mission to provide accessible, high-quality therapeutics for chronic and rare conditions, with a clear emphasis on patient-centered delivery systems. This recurring engagement reflects a trusted supplier status within VA’s pharmaceutical acquisition network, likely through FSS or blanket purchase agreements. Cosette’s primary NAICS code, 325412, reflects its core function as a contract manufacturer of finished pharmaceutical dosage forms, specifically injectables and autoinjectors. The firm is positioned as a niche supplier in the specialty drug manufacturing sector, serving markets requiring complex formulation and delivery technologies. Their focus on branded injectables indicates alignment with high-value, low-volume therapeutic segments. As a 2L entity based in South Plainfield, New Jersey, Cosette Pharmaceuticals operates as a mid-tier manufacturer with no public certifications listed. Its geographic location places it within a concentrated biopharmaceutical corridor, supporting regional supply chain efficiency for federal healthcare procurement. The company’s market positioning is defined by technical precision in sterile injectable manufacturing rather than broad-scale production.